Okita Riki 沖田理貴

… Alternative Names

沖田理貴オキタリキ

Less

Researcher Number	90467762
Other IDs
Affiliation (Current)	2025: 独立行政法人国立病院機構山口宇部医療センター(臨床研究部), その他部局等, 呼吸器外科医長
Affiliation (based on the past Project Information) *help	2018 – 2023: 独立行政法人国立病院機構山口宇部医療センター(臨床研究部), その他部局等, 呼吸器外科医長 2015 – 2017: 川崎医科大学, 医学部, 講師 2012 – 2013: 川崎医科大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Basic Section 55040:Respiratory surgery-related / Respiratory surgery / Thoracic surgery
Keywords	Principal Investigator NK細胞 / 非小細胞肺癌 / 腫瘍免疫 / 免疫チェックポイント / NKG2Dリガンド / 悪性胸膜中皮腫 / T細胞 / 予後解析 / 炎症 / 腫瘍微小環境 … More / PD-L1 / HER2 / EGFR / 胸水 / サイトカイン / 予後 / 腫瘍免疫微小環境 / 免疫チェックポイント分子 / ＮKG2Dリガンド / 栄養 / HLA class I / 腫瘍浸潤CD8T細胞 / 治療効果予測因子 / 予後因子 / 発現制御 / 免疫学 / 癌 / トランスレーショナルリサーチ / 外科 / microRNA / HER3 / IFNγ / 免疫逃避 / lung cancer / NKG2D ligand / NK cell / 肺癌 / 癌免疫療法 / NK細胞傷害活性 Less

Study for regulation mechanism of immunomodulatory molecules which are therapeutic targets for malignant pleural mesotheliomaPrincipal Investigator
- Principal Investigator
  
  沖田理貴
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  National Hospital Organization,Yamaguchi - Ube Medical Center
Development of immunomodulating therapy targeting immunocheckpoint moleules for NK cells in patients with malignant pleural mesothelioma.Principal Investigator
- Principal Investigator
  
  Okita Riki
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  National Hospital Organization,Yamaguchi - Ube Medical Center
Immunoescape mechanisms of thoracic malignancy via EGFR signalingPrincipal Investigator
- Principal Investigator
  
  Okita Riki
- Project Period (FY)
  2016 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory surgery
- Research Institution
  National Hospital Organization,Yamaguchi - Ube Medical Center
  Kawasaki Medical School
Immunoescape from innnate/adoptive antitumor immunity via EGF family receptor in non-small cell lung cancerPrincipal Investigator
- Principal Investigator
  
  Okita Riki
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory surgery
- Research Institution
  Kawasaki Medical School
非小細胞肺癌におけるHERシグナルを介した自然免疫逃避機構の解明Principal Investigator
- Principal Investigator
  
  沖田理貴
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Thoracic surgery
- Research Institution
  Kawasaki Medical School

All 2023 2022 2021 2019 2018 2017 2016 2015 2013 2012

All Journal Article Presentation

[Journal Article] Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis2023
- Author(s)
  Okita Riki、Kawamoto Nobutaka、Okada Masanori、Inokawa Hidetoshi、Yamamoto Naoki、Murakami Tomoyuki、Ikeda Eiji
- Journal Title
  
  Scientific Reports
  
  Volume: 13 Issue: 1 Pages: 5260-5266
- DOI
  10.1038/s41598-023-31448-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08991, KAKENHI-PROJECT-19K09298, KAKENHI-PROJECT-22K08057, KAKENHI-PROJECT-18K08005
[Journal Article] Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy2022
- Author(s)
  Okita Riki、Mimura-Kimura Yuka、Kawamoto Nobutaka、Yamamoto Naoki、Umeda Masashi、Okada Masanori、Inokawa Hidetoshi、Mimura Yusuke、Murakami Tomoyuki、Nakata Masao、Okabe Kazunori
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 72 Issue: 4 Pages: 865-879
- DOI
  10.1007/s00262-022-03292-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09298, KAKENHI-PROJECT-22K08057, KAKENHI-PROJECT-18K08005
[Journal Article] Prognostic values of preoperative C-reactive protein, albumin, and neutrophil ratios in patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy2022
- Author(s)
  Okita Riki、Okada Masanori、Inokawa Hidetoshi、Murakami Tomoyuki、Ikeda Eiji
- Journal Title
  
  Surgical Oncology
  
  Volume: 43 Pages: 101813-101813
- DOI
  10.1016/j.suronc.2022.101813
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K09298
[Journal Article] Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad2021
- Author(s)
  Okita Riki、Shimizu Katsuhiko、Nojima Yuji、Saisho Shinsuke、Nakata Masao
- Journal Title
  
  Thoracic Cancer
  
  Volume: 12 Issue: 6 Pages: 775-782
- DOI
  10.1111/1759-7714.13847
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09298
[Journal Article] Effect of platinum-based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death-1 ligand 1 and HLA class I in non-small cell lung cancer2019
- Author(s)
  Okita Riki、Ai Maeda、Shimizu Katsuhiko、Yuji Nojima、Shinsuke Saisho、Nakata Masao
- Journal Title
  
  ONCOLOGY REPORTS
  
  Volume: 印刷中
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10696
[Journal Article] Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer</p>2019
- Author(s)
  Shimizu Katsuhiko、Okita Riki、Saisho Shinsuke、Maeda Ai、Nojima Yuji、Nakata Masao
- Journal Title
  
  Therapeutics and Clinical Risk Management
  
  Volume: Volume 15 Pages: 605-612
- DOI
  10.2147/tcrm.s189320
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10696
[Journal Article] Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer2019
- Author(s)
  Okita Riki、Maeda Ai、Shimizu Katsuhiko、Nojima Yuji、Saisho Shinsuke、Nakata Masao
- Journal Title
  
  Oncotarget
  
  Volume: 10 Issue: 63 Pages: 6805-6815
- DOI
  10.18632/oncotarget.27308
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10696
[Journal Article] Effect of platinum-based chemotherapy on the expression of natural killer group?2 member?D ligands, programmed cell death?1 ligand?1 and HLA class?I in non?small cell lung cancer2019
- Author(s)
  Okita Riki、Maeda Ai、Shimizu Katsuhiko、Nojima Yuji、Saisho Shinsuke、Nakata Masao
- Journal Title
  
  Oncology Reports
  
  Volume: 42 Pages: 839-848
- DOI
  10.3892/or.2019.7185
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10696
[Journal Article] Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer2018
- Author(s)
  SHIMIZU KATSUHIKO、OKITA RIKI、SAISHO SHINSUKE、MAEDA AI、NOJIMA YUJI、NAKATA MASAO
- Journal Title
  
  Anticancer Research
  
  Volume: 38 Issue: 8 Pages: 4637-4644
- DOI
  10.21873/anticanres.12768
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10696
[Journal Article] Epithelial-mesenchymal transition-induced metastasis could be a bait for natural killer cells2018
- Author(s)
  Okita Riki、Shimizu Katsuhiko、Nakata Masao
- Journal Title
  
  Journal of Thoracic Disease
  
  Volume: 10 Issue: S26 Pages: S3143-S3146
- DOI
  10.21037/jtd.2018.08.19
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10696
[Journal Article] PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer2017
- Author(s)
  Riki Okita, Ai Maeda, Katsuhiko Shimizu, Yuji Nojima, Shinsuke Saisho, Masao Nakata.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: - Issue: 7 Pages: 865-876
- DOI
  10.1007/s00262-017-1986-y
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-16K10696
[Journal Article] Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer2017
- Author(s)
  Shimizu Katsuhiko、Okita Riki、Saisho Shinsuke、Maeda Ai、Nojima Yuji、Nakata Masao
- Journal Title
  
  Oncol Lett
  
  Volume: 14 Issue: 2 Pages: 1615-1620
- DOI
  10.3892/ol.2017.6340
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10696
[Journal Article] Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma.2017
- Author(s)
  Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M.
- Journal Title
  
  Cancer Manag Res
  
  Volume: 9 Pages: 741-750
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10696
[Journal Article] MHC class I chain‑related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non‑small cell lung cancer2016
- Author(s)
  Riki Okita1, Takuro Yukawa, Yuji Nojima, Ai Maeda, Shinsuke Saisho, Katsuhiko Shimizu, Masao Nakata
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 65 Issue: 5 Pages: 499-509
- DOI
  10.1007/s00262-016-1814-9
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25462189
[Journal Article] Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells2015
- Author(s)
  Riki Okita , Katsuhiko Shimizu, Yuji Nojima, Takuro Yukawa, Ai Maeda, Shinsuke Saisho, Masao Nakata.
- Journal Title
  
  Oncology Reports
  
  Volume: 34 Issue: 6 Pages: 2864-2870
- DOI
  10.3892/or.2015.4314
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25462189
[Journal Article] Contrasting effects of the cytotoxic anticancer drug Gemcitabine and the EGFR tyrosine kinase inhibitor Gefitinib on NK cell-mediated cytotoxicity via regulation of NKG2D ligand in non-small-cell lung cancer cells.2015
- Author(s)
  Okita R, Wolf D, Yasuda K, Maeda A, Yukawa T, Saisho S, Shimizu K, Yamaguchi Y, Oka M, Nakayama E, Lundqvist A, Kiessling R, Seliger B, Nakata M.
- Journal Title
  
  PLoS One
  
  Volume: 10 Issue: 10 Pages: e0139809-e0139809
- DOI
  10.1371/journal.pone.0139809
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-25430161, KAKENHI-PROJECT-25462189
[Presentation] 悪性胸膜中皮腫におけるBAP1 lossとMICA/B発現ならびに腫瘍浸潤リンパ球との関連性の検討2023
- Author(s)
  沖田理貴
- Organizer
  第36回日本バイオセラピィ学会学術集会総会
- Data Source
  KAKENHI-PROJECT-22K08991
[Presentation] 胸膜外肺全摘術を施行された悪性胸膜中皮腫症例におけるBAP1 lossと臨床病理学的因子との関連性の検討2023
- Author(s)
  沖田理貴、岡田真典、井野川英利
- Organizer
  第40回日本呼吸器外科学会学術集会
- Data Source
  KAKENHI-PROJECT-22K08991
[Presentation] 悪性胸膜中皮腫切除例における腫瘍浸潤NK細胞、MICA/B発現と予後との関連性についての検討2022
- Author(s)
  沖田理貴、川本常喬、岡田真典、井野川英利
- Organizer
  第39回日本呼吸器外科学会学術集会
- Data Source
  KAKENHI-PROJECT-19K09298
[Presentation] 胸膜外肺全摘術を施行された悪性胸膜中皮腫症例において術前末梢血好中球/リンパ球比は術後予後予測因子である2022
- Author(s)
  沖田理貴、梅田将志、岡田真典、井野川英利
- Organizer
  第97回中国四国外科学会総会
- Data Source
  KAKENHI-PROJECT-19K09298
[Presentation] Combinations of preoperative C-reactive protein with albumin or neutrophil ratio predict prognosis in patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy2022
- Author(s)
  Riki Okita, Masanori Okada, Hidetoshi Inokawa
- Organizer
  第75回日本胸部外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-19K09298
[Presentation] 胸膜外肺全摘術を施行された悪性胸膜中皮腫におけるPD-L1とHLA class I分子の発現解析2021
- Author(s)
  沖田理貴、川本常喬、岡田真典、林雅太郎、井野川英利、岡部和倫
- Organizer
  第38回日本呼吸器外科学会学術集会
- Data Source
  KAKENHI-PROJECT-19K09298
[Presentation] 胸膜外肺全摘術を施行された悪性胸膜中皮腫のHLA class I分子発現と腫瘍浸潤CD8 T細胞の解析2021
- Author(s)
  沖田理貴、川本常喬、岡田真典、井野川英利
- Organizer
  第62回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-19K09298
[Presentation] JAK STAT inhibitor overcomes interferon g reduced, NK cell mediated cytotoxicity in non small cell lung cancer cells2019
- Author(s)
  Okita Riki、Shimizu Katsuhiko、Nojima Yuji、Saisho Shinsuke、Nakata Masao
- Organizer
  European Society for Medical Oncology Congress 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] Decreased expression of ULBP4 without loss of MHC class I is an independent poor prognostic factor in resected NSCLC2019
- Author(s)
  沖田理貴、前田　愛、清水克彦、野島雄史、最相晋輔、中田昌男
- Organizer
  第72回日本胸部外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] 非小細胞肺癌切除検体におけるPD-L1とMICA/Bの発現解析2018
- Author(s)
  沖田理貴、清水克彦、野島雄史、最相晋輔、中田昌男
- Organizer
  第15回日本免疫治療学研究会学術集会
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] 非小細胞肺癌細胞における抗リウマチ薬TofacitinibのPD-L1発現抑制効果2018
- Author(s)
  沖田理貴、清水克彦、野島雄史、最相晋輔、中田昌男
- Organizer
  第35回日本呼吸器外科学会総会・学術集会
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] Relationship between PD-L1 expression and EGFR/HER2 signaling in non-small-cell lung cancer2017
- Author(s)
  Okita R, Maeda A, Shimizu K, Nojima Y, Saisho S, Nakata M.
- Organizer
  18th World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] Survival of non-small cell lung cancer patients predicted from expression of PD-L1, HLA class I and MICA/B on tumor cells2017
- Author(s)
  Okita R, Maeda A, Yukawa T, Shimizu K, Nojima Y, Saisho S, Nakata M.
- Organizer
  European Society for Medical Oncology 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] 非小細胞肺癌切除例におけるNKG2DリガンドULBP1-6の発現と臨床病理学的因子との関連性の検討2017
- Author(s)
  沖田理貴, 前田　愛, 清水克彦, 野島雄史, 最相晋輔, 中田昌男
- Organizer
  第70回日本胸部外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] シスプラチン併用導入化学療法が非小細胞肺癌における PD-L1発現に及ぼす影響2017
- Author(s)
  沖田理貴, 前田　愛, 野島雄史, 最相晋輔, 清水克彦, 中田昌男
- Organizer
  第34回日本呼吸器外科学会総会
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] PD-L1 expression predicts poor prognosis and is correlated with EGFR status in patients with non-small-cell lung cancer2016
- Author(s)
  沖田理貴, 野島雄史, 前田　愛, 最相晋輔, 清水克彦, 中田昌男
- Organizer
  第14回日本臨床腫瘍学会学術集会
- Place of Presentation
  神戸国際会議場、神戸市、兵庫県
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] Repeated exposure to cisplatin enhances NK cell-mediated cytotoxicity via up-regulation of NKG2D ligands in non-small cell lung cancer cells2016
- Author(s)
  Okita R, Nojima Y, Maeda A, Saisho S, Shimizu K, Nakata M
- Organizer
  European Society for Medical Oncology 2016
- Place of Presentation
  Copenhagen, Denmark
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] 非小細胞肺癌におけるPD-L1発現とHER2シグナルとの関連性の検討2016
- Author(s)
  沖田理貴, 中田昌男
- Organizer
  第29回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  久留米シティプラザ、久留米市、福岡県
- Data Source
  KAKENHI-PROJECT-16K10696
[Presentation] 非小細胞肺癌におけるNKG2DリガンドMICA/B発現の意義：切除例における予後との関連ならびにシスプラチンによるMICA/B発現誘導効果に関する検討2015
- Author(s)
  沖田理貴、湯川拓郎、野島雄史、前田　愛、最相晋輔、清水克彦、中田昌男
- Organizer
  第28回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  川越東武ホテル、川越市、埼玉県
- Year and Date
  2015-12-03
- Data Source
  KAKENHI-PROJECT-25462189
[Presentation] 悪性胸膜中皮腫細胞においてlapatinibはtrastuzumabの抗体依存性細胞傷害活性を増強する2015
- Author(s)
  沖田理貴、野島雄史、前田　愛、最相晋輔、清水克彦、中田昌男
- Organizer
  第6回　Japan Mesothelioma Interest Group 研究会
- Place of Presentation
  北九州国際会議場、北九州市、福岡県
- Year and Date
  2015-11-14
- Data Source
  KAKENHI-PROJECT-25462189
[Presentation] Overexpression of NK cell-activating ligand MICA/B correlates with superior outcomes and might be a therapeutic target for chemoimmunotherapy in non-small-cell lung cancer.2015
- Author(s)
  Riki Okita, Takuro Yukawa, Yuji Nojima, Ai Maeda, Shinsuke Saisho, Katsuhiko Shimizu, Masao Nakata
- Organizer
  ESMO Asia 2015
- Place of Presentation
  Singapore, Singapore
- Year and Date
  2015-12-19
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25462189
[Presentation] 化学療法前後における非小細胞肺癌細胞のNKG2Dリガンド発現解析2015
- Author(s)
  沖田理貴, 保田紘一郎, 前田　愛, 湯川拓郎, 最相晋輔, 清水克彦, 中田昌男
- Organizer
  第32回日本呼吸器外科学会総会
- Place of Presentation
  サンポートホール高松、高松市、香川県
- Year and Date
  2015-05-15
- Data Source
  KAKENHI-PROJECT-25462189
[Presentation] Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity by upregulating HER2 in malignant pleural mesothelioma cells.2015
- Author(s)
  Riki Okita, Shinji Nojima, Ai Maeda, Takuro Yukawa, Shinsuke Saisho, Katsuhiko Shimizu, Masao Nakata.
- Organizer
  The 2015 European Cancer Congress
- Place of Presentation
  Vienna, Austria
- Year and Date
  2015-09-28
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25462189
[Presentation] Anticancer drugs effect on NK cell-mediated cytotoxicity via the regulation of NKG2D ligand expression in non-small cell lung cancer cells2013
- Author(s)
  Okita R, Nojima Y, Yasuda K, Maeda A, Yukawa T, Saisho S, Hirami Y, Shimizu K, Nakata M
- Organizer
  European Cancer Congress 2013
- Place of Presentation
  Amsterdam, Netherlands
- Data Source
  KAKENHI-PROJECT-25462189
[Presentation] 非小細胞肺癌細胞において抗腫瘍薬がNK細胞傷害活性に与える影響の解析2013
- Author(s)
  沖田理貴、野島雄史、保田紘一郎、前田　愛、湯川拓郎、最相晋輔、清水克彦、中田昌男
- Organizer
  第54回日本肺癌学会総会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-25462189
[Presentation] EGFR signaling effects on NK cell-mediated cytotoxicity via NKG2D ligands-NKG2D interaction in non-small cell lung cancer cells2013
- Author(s)
  Okita R, Nojima Y, Yasuda K, Maeda A, Yukawa T, Saisho S, Hirami Y, Shimizu K, Nakata M
- Organizer
  15th World Conference on Lung Cancer
- Place of Presentation
  Sydney, Australia
- Data Source
  KAKENHI-PROJECT-25462189
[Presentation] HER signaling effects on the NK cell-mediated cytotoxicity via regulation of MHC class I-related chain A/ B in cancer cells2012
- Author(s)
  Riki Okita
- Organizer
  The 37th European Society for Medical Oncology Congress 2012
- Place of Presentation
  Vienna, Austria
- Data Source
  KAKENHI-PROJECT-24890284

1. NAKATA Masao (30368641)

# of Collaborated Projects: 3 results

# of Collaborated Products: 32 results
2. Kiessling Rolf

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. OKA Mikio

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Okita Riki 沖田 理貴

沖田 理貴 オキタ リキ

Research Projects

Research Products

Co-Researchers

Study for regulation mechanism of immunomodulatory molecules which are therapeutic targets for malignant pleural mesotheliomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of immunomodulating therapy targeting immunocheckpoint moleules for NK cells in patients with malignant pleural mesothelioma.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Immunoescape mechanisms of thoracic malignancy via EGFR signalingPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Immunoescape from innnate/adoptive antitumor immunity via EGF family receptor in non-small cell lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

非小細胞肺癌におけるHERシグナルを介した自然免疫逃避機構の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic values of preoperative C-reactive protein, albumin, and neutrophil ratios in patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effect of platinum-based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death-1 ligand 1 and HLA class I in non-small cell lung cancer2019

Author(s)

Journal Title

Data Source

[Journal Article] Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer</p>2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effect of platinum-based chemotherapy on the expression of natural killer group?2 member?D ligands, programmed cell death?1 ligand?1 and HLA class?I in non?small cell lung cancer2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Epithelial-mesenchymal transition-induced metastasis could be a bait for natural killer cells2018

Okita Riki 沖田理貴

沖田理貴オキタリキ

[Journal Article] MHC class I chain‑related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non‑small cell lung cancer2016

[Presentation] 胸膜外肺全摘術を施行された悪性胸膜中皮腫症例において術前末梢血好中球/リンパ球比は術後予後予測因子である2022